In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

Intranasal foralumab can modulate a number of immune cell types in people with non-active SPMS, developer Tiziana Life ...

A woman from Bicester, twice diagnosed with breast cancer before a secondary cancer diagnosis last year, will take part in a cancer charity fundraiser for the 19th time. Jeanette Watts, 64, was first ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, ...

Newer treatments target pathways like Delta-like ligand 3, poly-ADP-ribose polymerase, and histone deacetylase to address ...

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.

Welcome to your Cure magazine hub - your destination for the latest news from across Alzheimer’s Research UK. We exist for a cure. Thank you for standing with us. You are helping our scientists ...

Many of the estimated 1 million people in the U.S. with multiple sclerosis deal with eye and vision problems, as well as ...